A clinical research study is now enrolling people who may be at higher risk for complications from the flu.
Flu Prevention Study – Higher-Risk Individuals
Age Range:
18 to 100
Gender:
Male and Female
Location:
Buffalo, New York
About the Study
Researchers are evaluating an investigational medication to learn whether it may help prevent symptomatic influenza in people at higher risk due to age, certain health conditions, or a weakened immune system.
For some people, getting the flu can lead to more serious health complications. This may include older adults, people living with certain chronic health conditions, and people whose immune systems are weakened by a medical condition or treatment.
If you qualify and choose to participate, you will receive one injection of either the investigational medication or a placebo. The study is double-blind, meaning neither you nor the study team will know which one you receive during the study.
Participation lasts approximately 29 weeks, not including the screening period. During the study, participants will be asked to complete regular check-ins about possible flu-like symptoms and attend study visits as required.
Qualifications
You may qualify if you are age 18 or older and one of the following applies to you:
- You are 65 years of age or older, even if you are otherwise healthy
- You have certain health conditions that may increase your risk of complications from the flu, such as qualifying lung disease, moderate-to-severe asthma, heart disease, insulin-dependent diabetes, or kidney disease
- You have a weakened immune system because of certain health conditions, medications, cancer treatments, or a transplant
FEATURED STUDIES
Adults 18 years of age and older with elevated inflammation levels and heart disease or certain health conditions that increase […]
A clinical research study is now enrolling people who may be at higher risk for complications from the flu.
A clinical research study is now enrolling adults age 60 and older to evaluate an investigational vaccine designed to help […]
An upcoming clinical research study is evaluating an investigational long-acting approach designed to help prevent influenza. Join our interest list […]
Adults 65 and older may qualify for a clinical research study evaluating an investigational seasonal flu vaccine.
This clinical trial will help us learn if receiving another dose of the RSV vaccine is safe and can help […]